This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2005 by Johns Hopkins University.
Recruitment status was:  Active, not recruiting
Information provided by:
Johns Hopkins University Identifier:
First received: January 31, 2006
Last updated: NA
Last verified: August 2005
History: No changes posted
The purpose of this study is to compare 2 different cold storage solutions, used to preserve donor lungs for lung transplantation, and their effect on cytokine activation related to ischemic reperfusion injury. Primary endpoint is 30 day survival.

Condition Intervention Phase
Lung Transplant Recipients Device: Celsior Cold Storage Solution Phase 3

Study Type: Interventional
Official Title: A Prospective, Controlled, Randomized Study on the Effect of Cold Storage Solutions on Complement Activation and Other Mediators of Ischemic Injury in Lung Transplantation

Resource links provided by NLM:

Further study details as provided by Johns Hopkins University:

Study Start Date: December 2000
Estimated Study Completion Date: September 2005
Detailed Description:
The length of ischemic time in harvesting lung allografts is associated with graft survival. It is further thought that ischemic changes in early post-transplantation bronchoscopic biopsies has a direct correlation with later development of chronic rejection.

Ages Eligible for Study:   Child, Adult, Senior

Inclusion Criteria:

Any patient undergoing a lung trasnplant at Johns Hopkins Hospital -

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00284726

Sponsors and Collaborators
Johns Hopkins University
Principal Investigator: John V. Conte, M.D. Johns Hopkins University
  More Information Identifier: NCT00284726     History of Changes
Other Study ID Numbers: 00-10-25-03
Study First Received: January 31, 2006
Last Updated: January 31, 2006

Keywords provided by Johns Hopkins University:
Cytokines in lung transplantation
Cold storage solutions
Ischemic reperfusion injury

Additional relevant MeSH terms:
Pharmaceutical Solutions processed this record on August 17, 2017